In the previous example of cardiovascular diseases, suppose that the researcher has at his/her disposal, 300 patients with myocardial infarction (n 1 = 300), 300 patients with stroke (n 2 = 300), and 600 control subjects (n 0 = 600). A literature search revealed that the allele frequencies are p 1 = 0.158, p 2 = 0.149, and p 0 = 0.095, respectively. 1 Since , this researcher should combine both the patients with myocardial infarction and the patients with stroke as the case group. As for the example of prostate cancer, suppose that the researcher has at his/her disposal, a total of 100 prostate cancer cases, 20 of which were diagnosed at age р55 (n 1 = 20), and the remaining 80, at age Ͼ55 (n 2 = 80). He/she also has 100 control subjects (n 0 = 100) at his/her disposal. The a priori allele frequencies are p 1 = 0.430, p 2 = 0.090, and p 0 = 0.017, respectively. 2-4 Since , this time the researcher should discard the late-onset prostate cancer cases and focus his/her attention on the comparison between the 20 early-onset prostate cancer cases and the 100 control subjects. 
In the previous example of cardiovascular diseases, suppose that the researcher has at his/her disposal, 300 patients with myocardial infarction (n 1 = 300), 300 patients with stroke (n 2 = 300), and 600 control subjects (n 0 = 600). A literature search revealed that the allele frequencies are p 1 = 0.158, p 2 = 0.149, and p 0 = 0.095, respectively. 1 Since , this researcher should combine both the patients with myocardial infarction and the patients with stroke as the case group. As for the example of prostate cancer, suppose that the researcher has at his/her disposal, a total of 100 prostate cancer cases, 20 of which were diagnosed at age р55 (n 1 = 20), and the remaining 80, at age Ͼ55 (n 2 = 80). He/she also has 100 control subjects (n 0 = 100) at his/her disposal. The a priori allele frequencies are p 1 = 0.430, p 2 = 0.090, and p 0 = 0.017, respectively. 2-4 Since , this time the researcher should discard the late-onset prostate cancer cases and focus his/her attention on the comparison between the 20 early-onset prostate cancer cases and the 100 control subjects. Sirs-To study the genetic components of complex human diseases, researchers nowadays are relying heavily on the case-control association designs. However, they are often in a dilemma as to whether they should recruit as many affected cases as they can in a study (even though the affected cases recruited in this way may constitute a heterogeneous group), or whether they should instead insist on a stricter case definition to achieve greater homogeneity (even though this may result in a much smaller sample size). For example, suppose that a researcher intends to map the susceptibility gene(s) of cardiovascular diseases. Should he/she recruit both the patients with myocardial infarction and the patients with stroke as the case group in the study in order to increase the sample size? Or for the sake of homogeneity, should he/she recruit the patients with myocardial infarction (or stroke) only? As a second example, suppose that another researcher wishes to locate the susceptibility gene(s) of prostate cancer. He/she knows that the genetic contributions are larger in the earlier-onset prostate cancer cases than in the later-onset ones. However, the earlier-onset cases are limited in number. How should this researcher choose between greater homogeneity (only the early-onset cases are recruited) and larger sample size (both the early-onset and the late-onset cases are recruited)?
We propose a simple rule to help resolve the aforementioned dilemma. Assume that there are two types of affected cases. The allele frequency for the first (second) type of cases is denoted as p 1 (p 2 ), and the number of subjects, denoted as n 1 (n 2 ). We have a control group with allele frequency, p 0 , and the number of subjects, n 0 . Without loss of generality, we assume that the first type of affected cases is more genetically determined than the second, i.e.
. The proposed decision rule is that if , both types of affected cases should be recruited; otherwise, only the first type should be recruited. Case recruitment using this rule will achieve a higher statistical power (a proof is available from the authors). Note that the values of the allele frequencies, p 2 , p 1 , and p 0 should be obtained from a literature survey, or be estimated in a pilot study. 
